The activation of M&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt; muscarinic receptor reverses liver injuryvia the Sp1/lncRNA Gm2199/miR-212 axis

Zhang, Haiying; Gao, Ya; Liu, Bin; Hao, Jian; Li, Fan; Yang, Xi; Gao, Qiang; Yu, Yi; Guo, Yang; Liu, Yan

doi:10.3724/abbs.2022119

Cited by 1 publication

(1 citation statement)

References 80 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Specific protein 1 (SP1) is a transcription factor mediated by SUMOylation modifiers, which is upregulated in tumors; moreover, it often acts as a key regulator in inflammatory responses [ 10 , 11 ]. Studies have shown that SP1 is an activated transcription factor in primary OP, and its locus genotyping plays a vital role in OP [ 12 ].…”

Section: Introductionmentioning

confidence: 99%

SP1 regulates BMSC osteogenic differentiation through the miR-133a-3p/MAPK3 axis

Zhong,

Sun,

Wang

et al. 2024

J Orthop Surg Res

View full text Add to dashboard Cite

Background The progression of osteoporosis (OP) can dramatically increase the risk of fractures, which seriously disturb the life of elderly individuals. Specific protein 1 (SP1) is involved in OP progression. However, the mechanism by which SP1 regulates OP progression remains unclear. Objective This study investigated the mechanism underlying the function of SP1 in OP. Methods SAMP6 mice were used to establish an in vivo model of age-dependent OP, and BALB/c mice were used as controls. BMSCs were extracted from two subtypes of mice. Hematoxylin and eosin staining were performed to mark the intramedullary trabecular bone structure to evaluate histological changes. ChIP assay was used to assess the targeted regulation between SP1 and miR-133a-3p. The binding sites between MAPK3 and miR-133a-3p were verified using a dual-luciferase reporter assay. The mRNA levels of miR-133a-3p and MAPK3 were detected using quantitative reverse transcription polymerase chain reaction (RT-qPCR). The protein expression of SP1, MAPK3, Colla1, OCN, and Runx2 was examined using Western blotting. Alkaline phosphatase (ALP) kit and Alizarin Red S staining were used to investigate ALP activity and mineralized nodules, respectively. Results The levels of SP1 and miR-133a-3p were upregulated, whereas the expression of MAPK3 was downregulated in BMSCs from SAMP6 mice, and miR-133a-3p inhibitor accelerated osteogenic differentiation in BMSCs. SP1 directly targeted miR-133a-3p, and MAPK3 was the downstream mRNA of miR-133a-3p. Mechanically, SP1 accelerated osteogenic differentiation in BMSCs via transcriptional mediation of the miR-133a-3p/MAPK3 axis. Conclusion SP1 regulates osteogenic differentiation by mediating the miR-133a-3p/MAPK3 axis, which would shed new light on strategies for treating senile OP.

show abstract

Section: Introductionmentioning

confidence: 99%